Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

CCN AMERICA — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

CCN AMERICA

via K&L GATES, LLP

2nd Quarter (Apr 1 - June 30) · 2015Posted Jul 21, 2015Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: CCN AMERICA
Description: Provides 340b pharmacy and case management services.
Location: Pennsylvania · United States of America

Registrant

Firm: K&L GATES, LLP
Description: Law firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
H.R. 6, 21st Century Cures Act: 34b provisions.
LobbyistsSTEPHEN COOPER · RYAN SEVERSON · BART GORDON
TargetedHOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.